Advertisement
Research Article

The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with Advanced Colorectal Cancer

  • Masanobu Takahashi,

    Affiliation: Gastrointestinal Cancer Research Laboratory, Baylor Research Institute and Charles A Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, United States of America

    X
  • Miriam Cuatrecasas,

    Affiliation: Pathology Department, Centro de Diagnóstico Biomédico (CDB), Tumour Bank, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Biobank Hospital Clínic, University of Barcelona, Barcelona, Spain

    X
  • Francesc Balaguer,

    Affiliation: Gastroenterology Department, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), IDIBAPS, University of Barcelona, Barcelona, Spain

    X
  • Keun Hur,

    Affiliation: Gastrointestinal Cancer Research Laboratory, Baylor Research Institute and Charles A Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, United States of America

    X
  • Yuji Toiyama,

    Affiliation: Gastrointestinal Cancer Research Laboratory, Baylor Research Institute and Charles A Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, United States of America

    X
  • Antoni Castells,

    Affiliation: Gastroenterology Department, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), IDIBAPS, University of Barcelona, Barcelona, Spain

    X
  • C. Richard Boland mail,

    rickbo@baylorhealth.edu (CRB); ajay.goel@baylorhealth.edu (AG)

    Affiliation: Gastrointestinal Cancer Research Laboratory, Baylor Research Institute and Charles A Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, United States of America

    X
  • Ajay Goel mail

    rickbo@baylorhealth.edu (CRB); ajay.goel@baylorhealth.edu (AG)

    Affiliation: Gastrointestinal Cancer Research Laboratory, Baylor Research Institute and Charles A Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, United States of America

    X
  • Published: October 03, 2012
  • DOI: 10.1371/journal.pone.0046684

Reader Comments (0)

Post a new comment on this article